» Articles » PMID: 34640574

The Role of CEUS in the Evaluation of Thyroid Cancer: From Diagnosis to Local Staging

Abstract

Ultrasound often represents the first diagnostic step for thyroid nodule evaluation in clinical practice, but baseline US alone is not always effective enough to achieve thyroid nodule characterization. In the last decades new ultrasound techniques, such as CEUS, have been introduced to evaluate thyroid parenchyma as recommended by EFSUMB guidelines, for use in clinical research field, although its role is not yet clear. Several papers show the potential utility of CEUS in the differential diagnosis of benign and malignant thyroid nodules and in the analysis of lymph node involvement in neoplastic pathology. Therefore, we carried out an evaluation of the literature concerning the role of CEUS in three specific areas: the characterization of the thyroid nodule, the evaluation of minimally invasive treatment and loco-regional staging of the lymph node in proven thyroid cancer. According to evidence reported, CEUS can also play an operative role in nodular thyroid pathology as it is able to guide ablation procedures on thyroid nodule and metastatic lymph nodes, to assess the radicality of surgery, to evaluate disease relapse at the level of the margins of ablated regions and to monitor the clinical evolution of necrotic areas in immediate post-treatment setting.

Citing Articles

Role of Ultrasound Elastography and Contrast-Enhanced Ultrasound (CEUS) in Diagnosis and Management of Malignant Thyroid Nodules-An Update.

Solomon C, Petea-Balea D, Dudea S, Bene I, Silaghi C, Lenghel M Diagnostics (Basel). 2025; 15(5).

PMID: 40075847 PMC: 11898416. DOI: 10.3390/diagnostics15050599.


Diagnostic efficacy of data mining method based on multimodal ultrasound for papillary thyroid carcinoma.

Xu C, Zhang L, Zhang Q, Wang T, Wu Y, Yao J Front Oncol. 2024; 14:1439825.

PMID: 39512776 PMC: 11540824. DOI: 10.3389/fonc.2024.1439825.


Sonographic characteristics of thyroid nodules with a Halo.

Cao D, Zou R, Zhang M, Tang K Thyroid Res. 2024; 17(1):20.

PMID: 39350176 PMC: 11443876. DOI: 10.1186/s13044-024-00208-5.


Enhancing diagnostic precision in thyroid nodule assessment: evaluating the efficacy of a novel cell preservation technique in fine-needle aspiration cytology.

Streinu D, Neagoe O, Borlea A, Icma I, Derban M, Stoian D Front Endocrinol (Lausanne). 2024; 15:1438063.

PMID: 39280002 PMC: 11393782. DOI: 10.3389/fendo.2024.1438063.


Thyroid Nodule Characterization: Overview and State of the Art of Diagnosis with Recent Developments, from Imaging to Molecular Diagnosis and Artificial Intelligence.

David E, Grazhdani H, Tattaresu G, Pittari A, Foti P, Palmucci S Biomedicines. 2024; 12(8).

PMID: 39200141 PMC: 11351886. DOI: 10.3390/biomedicines12081676.


References
1.
Xiang D, Hong Y, Zhang B, Huang P, Li G, Wang P . Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients: diagnosis value and enhancement patterns of malignant lymph nodes. Eur Radiol. 2014; 24(10):2513-9. DOI: 10.1007/s00330-014-3288-5. View

2.
Zhang M, Tufano R, Russell J, Zhang Y, Zhang Y, Qiao Z . Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up. Thyroid. 2020; 30(3):408-417. DOI: 10.1089/thy.2019.0147. View

3.
Schleder S, Janke M, Agha A, Schacherer D, Hornung M, Schlitt H . Preoperative differentiation of thyroid adenomas and thyroid carcinomas using high resolution contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc. 2014; 61(1):13-22. DOI: 10.3233/CH-141848. View

4.
Zhan J, Diao X, Chen Y, Wang W, Ding H . Homogeneity Parameter in Contrast-Enhanced Ultrasound Imaging Improves the Classification of Abnormal Cervical Lymph Node after Thyroidectomy in Patients with Papillary Thyroid Carcinoma. Biomed Res Int. 2019; 2019:9296010. PMC: 6899314. DOI: 10.1155/2019/9296010. View

5.
Yan L, Lan Y, Xiao J, Lin L, Jiang B, Luo Y . Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2020; 31(2):685-694. DOI: 10.1007/s00330-020-07128-6. View